Yuan Gao1, Hao Meng2, Yemin Zhang3, Tingting Jiao3, Ning Hui3. 1. Department of Gynecology and Obstetrics, Changhai Hospital of Secondary Military Medical University Shanghai, 200433, China ; Department of Gynecology and Obstetrics, General Hospital of PLA Beijing, 100853, China. 2. Department of Orthopedics, Air Force General Hospital Beijing, 100142, China ; Department of Orthopedics, Military General Hospital of Beijing PLA Beijing, 100700, China. 3. Department of Gynecology and Obstetrics, Changhai Hospital of Secondary Military Medical University Shanghai, 200433, China.
Abstract
OBJECTIVE: Uterine sarcomas are rare gynecological malignancies with poor prognosis and high mortality. We provides clinical information of uterine sarcoma patients at Changhai Hospital of Secondary Military Medical University in Shanghai, China, over a 20-year period. DESIGN AND METHODS: Satisfied the criteria for the study, a total of 80 female patients with uterine sarcomas were retrospectively evaluated. Overall survival was analyzed by Kaplan-Meier method. MAIN OUTCOME MEASURES: The following information was extracted from our medical records: age, presentations, blood types, stages, ultrasonographic results, therapies and follow-up. RESULTS: Of the 80 patients, the mean age of onset was 57.3±2.03 years, and the highest frequency occurred in 51-60 age group. Endometrial stromal sarcoma was the most common histological type (47.5%). Even population of these patients presented was with early stage (I&II) and advanced stages (III&IV). Among 79 patients underwent primary surgery, 74 cases was hysterectomy and bilateral salping-ooophorectomy. Equal to disease-specific survival, overall survival rates at 1-, 3- and 5-year were 81.3%, 62.5% and 40% respectively. Age, menopausal status, blood type, stage, and pathologic types were all proved to be correlated with the survival. CONCLUSION: Our retrospective data in part reflect clinical characteristics of uterine sarcoma in China, and form the basis for further concerning researches.
OBJECTIVE: Uterine sarcomas are rare gynecological malignancies with poor prognosis and high mortality. We provides clinical information of uterine sarcomapatients at Changhai Hospital of Secondary Military Medical University in Shanghai, China, over a 20-year period. DESIGN AND METHODS: Satisfied the criteria for the study, a total of 80 female patients with uterine sarcomas were retrospectively evaluated. Overall survival was analyzed by Kaplan-Meier method. MAIN OUTCOME MEASURES: The following information was extracted from our medical records: age, presentations, blood types, stages, ultrasonographic results, therapies and follow-up. RESULTS: Of the 80 patients, the mean age of onset was 57.3±2.03 years, and the highest frequency occurred in 51-60 age group. Endometrial stromal sarcoma was the most common histological type (47.5%). Even population of these patients presented was with early stage (I&II) and advanced stages (III&IV). Among 79 patients underwent primary surgery, 74 cases was hysterectomy and bilateral salping-ooophorectomy. Equal to disease-specific survival, overall survival rates at 1-, 3- and 5-year were 81.3%, 62.5% and 40% respectively. Age, menopausal status, blood type, stage, and pathologic types were all proved to be correlated with the survival. CONCLUSION: Our retrospective data in part reflect clinical characteristics of uterine sarcoma in China, and form the basis for further concerning researches.
Authors: D Lawrence Wickerham; Bernard Fisher; Norman Wolmark; John Bryant; Joseph Costantino; Leslie Bernstein; Carolyn D Runowicz Journal: J Clin Oncol Date: 2002-06-01 Impact factor: 44.544
Authors: S Suchetha; T Vijayashanti; P Rema; J Sivaranjith; Aswin Kumar; K M Jagathnath Krishna; Francis V James Journal: J Obstet Gynaecol India Date: 2022-02-23
Authors: Maria Ruiz-Minaya; Elsa Mendizabal-Vicente; Wenceslao Vasquez-Jimenez; Laura Perez-Burrel; Irene Aracil-Moreno; Carolina Agra-Pujol; Mireia Bernal-Claverol; Beatriz L Martínez-Bernal; Mercedes Muñoz-Fernández; Melanie Morote-Gonzalez; Miguel A Ortega; Santiago Lizarraga-Bonelli; Juan A De Leon-Luis Journal: J Pers Med Date: 2022-02-06